Are you a journalist? Please sign up here for our press releases
Subscribe to our monthly newsletter:
Michel Revel
19.05.2013
Yeda Research and Development Company, Ltd., was established in 1959 to...
12.09.2010
A drug developed by InterPharm Laboratories Ltd. was first isolated and cloned by Prof. Michel Revel.
08.09.2010
Prof. Michel Revel spent more than 30 years studying interferons, which play a key role in the immune system. In the late 1970s, he isolated the...
09.09.2006
Prof. Michel Revel was elected a member of the Israel Academy of Sciences and Humanities.
01.07.2004
Biochemistry, Cancer, Personalized Medicine, Molecular and Cell Biology, Immunology, Disease, Drugs & Diagnostics, Fertility, Genetics, Technology & Applications, Benefiting Humanity
Are Human Rights and Human Traditions Threatened by Scientific Progress?
01.05.2001
Prof. Haim Aviv is starting his sixth bio-tech company
01.10.1999
A method developed in Institute labs could keep stem cells "fresh" for longer
01.08.1999
Weizmann Institute researchers have developed a molecule that allows blood stem cells - the body's most primitive, immature...
01.10.1997
Clinical trials of the multiple sclerosis drug, Rebif, are proving its effectiveness
